FDA Inspection
K. W. Griffen Company DBA Biomed Packaging SystemsK. W. Griffen Company DBA Biomed Packaging Systems – FDA Inspection, Mar 15, 2024
Record Details
This FDA Inspection record concerns K. W. Griffen Company DBA Biomed Packaging Systems, with an inspection on March 15, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 15, 2024
- Product Type
- Drugs
View Company Profile
ID · 545b8e3b-e17f-473a-9285-fbb36fc03724
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1232979
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
5- 21 CFR 314.81(b)(2)Timely submission
- 21 CFR 314.80(c)(2)Interval
- 21 CFR 314.80(b)Failure to develop written procedures
- 21 CFR 314.80(j)Failure to maintain records
- 21 CFR 314.80(c)(2)(ii)(A)Incomplete periodic safety report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of K. W. Griffen Company DBA Biomed Packaging Systems
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2025 | VAI | New England District Office | Drug Quality Assurance |
| August 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 18, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for K. W. Griffen Company DBA Biomed Packaging Systems
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.